Interestingly, in FMF, up to 3% of the patients will eventually develop often seronegative (HLAB27) spondyloarthropathy, mainly sacroiliitis [49,50]. IL-18 is known as an inducer / activator of type-1 responses in innate cells (like NK cells, macrophages and innate lymphoid cells) as ...